Undisclosed immunomodulators
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Undisclosed immunomodulators, covering 2026-04-17 to 2026-04-17. Get the full timeline:
Most recent: Clinical Trial Update: Study of Novel Immunomodulators as Monotherapy and in Combination With Anticancer Agents in Participants With Advanced Hepatobiliary Cancer [Phase 2]